Abstract
AbstractAn 8‐year‐old male neutered golden retriever diagnosed with a T‐cell lymphoma and treated with a modified LOPP (lomustine, vincristine, prednisolone and procarbazine) protocol was presented to a referral hospital for management of an accidental overdose of lomustine (180 mg/m2). This overdose resulted in a severe myelosuppression with neutropenia and thrombocytopenia. The human platelet stimulator eltrombopag was used as part of the treatment protocol, alongside granulocyte‐macrophage colony‐stimulating factor and supportive care. The dog made a good recovery and completed a course of chemotherapy, achieving complete clinical remission of the lymphoma and long‐term survival (613 days).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
